OPGEN INC (OPGN) earnings
OPGN earnings moved a median of +1.11% by the close. Quarterly and annual OPGN reports and results, each read against the price at its own news timestamp. Back to the OPGN overview →
21 measured OPGN earnings events.
Where these OPGN earnings landedvs 18 measured OPGN earnings reactions
| Middle 50% of OPGN earnings reactions | -4.74% to +3.98% |
|---|---|
| Median reaction (to close) | +1.11% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 OPGN earnings events with a measured close landed between -4.74% and +3.98%; 61% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q OPGEN INC For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -10.00% | |
| Form NT 10-Q OPGEN INC For: Sep 30 | SEC filing · Form NT | +19.05% | -33.33% | |
| Form 10-Q OPGEN INC For: Jun 30 | SEC filing · Form 10-Q | +15.14% | — | |
| Form 10-Q OPGEN INC For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K OPGEN INC For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| Form NT 10-Q OPGEN INC For: Jun 30 | SEC filing · Form NT | — | — | |
| Form NT 10-Q OPGEN INC For: Mar 31 | SEC filing · Form NT | +0.00% | +4.04% | |
| Form NT 10-K OPGEN INC For: Dec 31 | SEC filing · Form NT | +0.00% | +3.78% | |
| Form 10-Q OPGEN INC For: Sep 30 | SEC filing · Form 10-Q | +2.63% | +2.63% | |
| Form NT 10-Q OPGEN INC For: Sep 30 | SEC filing · Form NT | +4.21% | +2.37% | |
| Form 10-Q OPGEN INC For: Jun 30 | SEC filing · Form 10-Q | +11.43% | +37.14% | |
| Form 10-Q/A OPGEN INC For: Mar 31 | SEC filing · Form 10-Q | +11.43% | +37.14% | |
| Form NT 10-Q OPGEN INC For: Jun 30 | SEC filing · Form NT | +0.00% | +0.00% | |
| Form 10-Q OPGEN INC For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +6.54% | |
| Form 10-K OPGEN INC For: Dec 31 | SEC filing · Form 10-K | +0.00% | +12.50% | |
| OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q | Press release | +2.76% | +1.23% | |
| Form NT 10-Q OPGEN INC For: Mar 31 | SEC filing · Form NT | -3.40% | -12.47% | |
| OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K | Press release | +0.00% | -6.32% | |
| Form NT 10-K OPGEN INC For: Dec 31 | SEC filing · Form NT | -2.56% | -12.28% | |
| Form 10-Q OPGEN INC For: Sep 30 | SEC filing · Form 10-Q | +0.99% | +0.99% | |
| OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | +0.99% | +0.99% |
Keep exploring
More OPGN: analyst actions → · SEC filings → · OPGN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | 129 | -0.18% | 44% |
| Medicenna Therapeutics Corp (MDNA_TSE) | 127 | 0.00% | 46% |
| Orgenesis Inc. (ORGS) | 127 | +0.01% | 52% |
| AFFYMAX INC (AFFY) | 126 | +0.16% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.